Tech Company Financing Transactions
TyRx Pharma Funding Round
TyRx Pharma closed a $2 million venture capital round on 5/16/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/16/2013
Transaction Type
Venture Equity
Amount
$1,999,999
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Deer Park Drive G
Monmouth Junction, NJ 08852
USA
Monmouth Junction, NJ 08852
USA
Phone
Website
Email Address
Overview
TyRx is dedicated to designing, developing, and commercializing next-generation resorbable polymeric biomaterials. The Company's first series of tyrosine-based resorbable polymer systems have been created for use in drug delivery and medical device applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert White
Chief Financial Officer
Ray Imp
Chief Medical Officer
Daniel Lerner
VP - Marketing
Randy Mansfield
VP - Product Management
William McJames
VP - Regulatory Affairs
Mark Citron
VP - Regulatory Affairs
Susan Olinger
VP - Sales
Fernando Ochoa
Browse more venture capital transactions:
Prev: 5/16/2013: Qualtre venture capital transaction
Next: 5/16/2013: Ringadoc venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs